Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/01/2026 ,inter alia, to consider and approve to consider and approve Unaudited ....
ROSSARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Rossari Biotech has informed BSE that its Board of Directors will meet on January 17, 2026 to consider and approve the Unaudited Financial Results (both Standalone and Consolidated) for the quarter and nine months ended December 31, 2025. The intimation is filed under SEBI LODR Regulations 29 and 33. The trading window for designated persons and their immediate relatives is already closed from January 01, 2026 and will remain closed until 48 hours after the results are announced. The company has also stated that this notice is available on its website at www.rossari.com.
This is a routine regulatory intimation with no actual financial numbers disclosed yet. Investors should watch for the Q3 results announcement on or after January 17, 2026, which will provide actual performance visibility for the quarter.